Literature DB >> 35399179

Efficacy of Pre-operative 18F-FDG PET/CT in Prognostic Prediction in Patients With Renal Cell Carcinoma.

Masafumi Toguchi1, Kousei Ishigami2, Masato Goya3, Seiichi Saito3, Sadayuki Murayama4, Akihiro Nishie5.   

Abstract

Background/Aim: This study analyzed the parameters provided by preoperative 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for prognostic prediction of renal cell carcinoma (RCC). Patients and
Methods: FDG-PET/CT data from 66 clear cell RCC and 19 non-clear cell RCC cases between January 2015 and October 2018 were reviewed retrospectively. We compared the two groups according to recurrence/metastasis to determine prognosis-influencing factors. Multivariate Cox hazard regression models were constructed to evaluate factors potentially predicting disease-free survival (DFS) after adjustment for confounders. DFS was then compared between groups.
Results: Standardized uptake values (SUV) of the PET/CT scan were independent predictors of prognosis after adjusting for confounders. RCC cases were divided into two groups by optimal cut-off values. Differences between DFS percentages in high and low SUV groups were significant. Similar results were obtained in clear cell RCC groups.
Conclusion: Increased SUV of the PET/CT scan are significant predictors of worse prognoses in patients with surgically resected RCC. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  CT; PET; Renal cell carcinoma; disease-free survival; prognosis

Year:  2022        PMID: 35399179      PMCID: PMC8962815          DOI: 10.21873/cdp.10097

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  18 in total

1.  18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.

Authors:  Yoshifumi Noda; Masayuki Kanematsu; Satoshi Goshima; Natsuko Suzui; Yoshinobu Hirose; Kengo Matsunaga; Hironori Nishibori; Hiroshi Kondo; Haruo Watanabe; Hiroshi Kawada; Nobuyuki Kawai; Yukichi Tanahashi; Kyongtae T Bae
Journal:  Eur Radiol       Date:  2015-04-09       Impact factor: 5.315

2.  GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome.

Authors:  Salma Meziou; Cassandra Ringuette Goulet; Hélène Hovington; Véronique Lefebvre; Étienne Lavallée; Michelle Bergeron; Hervé Brisson; Audrey Champagne; Bertrand Neveu; Didier Lacombe; Jean-Mathieu Beauregard; François-Alexandre Buteau; Julie Riopel; Frédéric Pouliot
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-01-13       Impact factor: 5.554

3.  Evaluation of renal cell carcinoma histological subtype and fuhrman grade using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.

Authors:  Reiko Nakajima; Sayumi Nozaki; Tsunenori Kondo; Yoji Nagashima; Koichiro Abe; Shuji Sakai
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

4.  18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.

Authors:  Jiri Ferda; Eva Ferdova; Milan Hora; Ondrej Hes; Jindrich Finek; Ondrej Topolcan; Boris Kreuzberg
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

5.  Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.

Authors:  Choichi Horiuchi; Mamoru Tsukuda; Takahide Taguchi; Yukari Ishiguro; Koji Okudera; Tomio Inoue
Journal:  Ann Nucl Med       Date:  2008-11-04       Impact factor: 2.668

6.  Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.

Authors:  Kazuhiro Namura; Ryogo Minamimoto; Masahiro Yao; Kazuhide Makiyama; Takayuki Murakami; Futoshi Sano; Narihiko Hayashi; Ukihide Tateishi; Hanako Ishigaki; Takeshi Kishida; Takeshi Miura; Kazuki Kobayashi; Sumio Noguchi; Tomio Inoue; Yoshinobu Kubota; Noboru Nakaigawa
Journal:  BMC Cancer       Date:  2010-12-03       Impact factor: 4.430

7.  Can Initial (18)F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma?

Authors:  Haejun Lee; Kyung Hoon Hwang; Seog Gyun Kim; Geon Koh; Ji Hyun Kim
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

8.  Fructose 1,6-Bisphosphatase 1 Expression Reduces 18F-FDG Uptake in Clear Cell Renal Cell Carcinoma.

Authors:  Ruohua Chen; Xiang Zhou; Gang Huang; Jianjun Liu
Journal:  Contrast Media Mol Imaging       Date:  2019-01-06       Impact factor: 3.161

9.  FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma.

Authors:  Violetta Pankowska; Bogdan Malkowski; Mateusz Wedrowski; Ewelina Wedrowska; Krzysztof Roszkowski
Journal:  Clin Exp Med       Date:  2018-11-28       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.